Muslim Farooque

Analyst and Contributor at GuruFocus

Analyst and Contributor at Seeking Alpha

Articles

Nvidia, AMD Face Billions in Revenue Risk as J.P. Morgan Cuts EP

1 week ago | gurufocus.com | Muslim Farooque

J.P. Morgan is warning that newly imposed U.S. export restrictions on AI chips could reduce 2025 earnings per share (EPS) by 8% to 10% for both Nvidia (NVDA, Financial) and Advanced Micro Devices (AMD, Financial). The analysis follows the U.S. government's move to require special licenses for exporting Nvidia's H20 and AMD's MI308 chips to China. Nvidia has already flagged a $5.5 billion inventory charge tied to halted shipments, while AMD expects an $800 million hit.
Nvidia, Palantir Slide After U.S. Bars Chinese AI Firm DeepSeek

1 week ago | gurufocus.com | Muslim Farooque

U.S. tech stocks took a hit after the Trump administration barred DeepSeek—a fast‑growing Chinese AI startup—from accessing American technology, raising fresh concerns about just how much domestic chipmakers are exposed to the escalating U.S.–China tech standoff. Nvidia (NVDA, Financial), AMD (AMD, Financial) and Palantir (PLTR, Financial) were among the hardest hit as investors tried to gauge what this latest move means for the future of high‑end chip exports and AI momentum.
Target Climbs as CEO Plans Sharpton Meeting to Ease DEI Tensions

1 week ago | gurufocus.com | Muslim Farooque

Target (TGT, Financial) shares climbed more than 2.5% on Thursday after news broke that CEO Brian Cornell is preparing to meet with civil rights leader Rev. Al Sharpton to discuss the company's recent pullback on diversity, equity, and inclusion (DEI) initiatives. The move comes as Target faces mounting pressure from both activists and customers, and amid declining store traffic tied to a six-week â€śTarget fastâ€ť protest.
Kinder Morgan Keeps Outlook Steady, Sees Natural Gas Demand Boom

1 week ago | gurufocus.com | Muslim Farooque

Kinder Morgan (KMI, Financial) shares rose Thursday after the company reaffirmed its full-year profit forecast . Management struck a confident tone on the long-term demand for natural gas and played down concerns around the potential financial drag from tariffs on liquefied natural gas (LNG) exports. The pipeline giant maintained its guidance for 2025 adjusted earnings at $1.27 per share, just below the $1.28 consensus.
Intel at Risk in China as U.S.-Made Chips Face Tariffs Up to 125

1 week ago | gurufocus.com | Muslim Farooque

Intel (INTC, Financial) following Beijing's new tariff measures targeting U.S.-made goods, according to a note from Wells Fargo. The firm highlighted that China accounted for 29% of Intel's revenue in 2024, making the company particularly exposed to the policy shift. Beijing recently imposed tariffs of up to 125% on U.S. products in response to American trade restrictions. But Chinese regulators are treating semiconductors differently depending on where they're manufactured.
Tariff Uncertainty Pressures PayPal, BILL as Seaport Issues Down

1 week ago | gurufocus.com | Muslim Farooque

PayPal (PYPL, Financial) and Bill Holdings (BILL, Financial), citing growing macroeconomic uncertainty and rising trade tensions. The firm points to a â€śtariff-heavy worldâ€ť as a key reason for its more cautious stance. PayPal was cut from Neutral to Sell, over the company's mid-term forecast of 8% to 10% growth in Checkout total payment volume.
Goldman Sachs Warns of $800B U.S. Selloff in Worst-Case China Sp

1 week ago | gurufocus.com | Muslim Farooque

Goldman Sachs (GS, Financial) has issued a stark warning about the financial fallout that could follow a full-scale economic decoupling between the U.S. and China. In what it calls an â€śextreme scenario,â€ť the investment bank estimates U.S. investors could be forced to offload as much as $800 billion in Chinese equities. The analysis comes amid heightened trade tensions and rising concern over the potential delisting of major Chinese firms from U.S. stock exchanges.
Eli Lilly Soars as Oral Diabetes Pill Hits Targets in Phase 3

1 week ago | gurufocus.com | Muslim Farooque

Eli Lilly (LLY, Financial) shares surged around 14% in premarket trading Thursday after the company for orforglipron, its once-daily oral GLP-1 drug for type 2 diabetes. In its ACHIEVE-1 trial, the drug met its primary goal of reducing A1Câ€”a key diabetes markerâ€”by 1.3% to 1.6% across three dose levels from a baseline of 8.0%. The placebo group, by comparison, saw just a 0.1% reduction.
Evercore Backs Apple's Resilience as Global Tariffs Loom

1 week ago | gurufocus.com | Muslim Farooque

and $250 price target on Apple (AAPL, Financial), highlighting the company's efforts to manage supply chain risk amid rising U.S.â€“China trade tensions. Analysts led by Amit Daryanani pointed to Apple's diversified production footprint as a key buffer against targeted tariffs. Although Apple still relies heavily on China for manufacturing, the analysts noted that the company has steadily expanded production into India and Vietnam.
Nvidia's CEO Heads to Beijing as U.S. Chip Curbs Disrupt China B

1 week ago | gurufocus.com | Muslim Farooque

Nvidia (NVDA, Financial) for meetings with Chinese officials and industry leaders, just weeks after the U.S. imposed new restrictions on AI chip exports to China. This marks Huang's second visit to the country in the past three months. The trip comes in the wake of updated U.S. export rules that now require a license to ship Nvidia's H20 chips to Chinese customers.